Emergex Vaccines Holding
Latest round
- Series A
Last raised
- Sep 2019
Total raised
- $12M
Investors
- 2
About Emergex Vaccines Holding
Founded in 2016 and based in Abingdon, UK, Emergex Vaccines Holding Limited operates as a biopharmaceutical company that provides vaccines for viral and bacterial infectious diseases such as dengue fever, zika, ebola, and pandemic flu.
Who invested in Emergex Vaccines Holding
2 investors across 2 rounds
See all investors in Emergex Vaccines Holding
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Emergex Vaccines Holding
Who invested in Emergex Vaccines Holding?
Emergex Vaccines Holding has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emergex Vaccines Holding raised?
Emergex Vaccines Holding has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Emergex Vaccines Holding last raise money?
Emergex Vaccines Holding's most recent round on record is a Series A, in Sep 2019.
What does Emergex Vaccines Holding do?
Founded in 2016 and based in Abingdon, UK, Emergex Vaccines Holding Limited operates as a biopharmaceutical company that provides vaccines for viral and bacterial infectious diseases such as dengue fever, zika, ebola, and pandemic flu.
Where is Emergex Vaccines Holding headquartered?
Emergex Vaccines Holding is headquartered in UK.
Which VCs invest in companies like Emergex Vaccines Holding?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Emergex Vaccines Holding's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Emergex Vaccines Holding? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.